Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Tasleem J Padamsee"'
Autor:
Tasleem J Padamsee, Anna Muraveva, Rachel J Meadows, Megan Hils, Lisa D Yee, Celia E Wills, Electra D Paskett
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0278742 (2023)
PurposeWomen at high risk of breast cancer face complex decisions about how to manage those risks. Substantial gaps in current knowledge include how women make these decisions and how decision making may differ across sub-populations. Among these cri
Externí odkaz:
https://doaj.org/article/f5c4b7ee4e7e4e8d840352a2f75cbe13
Autor:
Deloris J. Veney, Lai Y. Wei, Amanda E. Toland, Carolyn J. Presley, Heather L. Hampel, Tasleem J. Padamsee, Clara N. Lee, William J. Irvin Jr, Michael J. Bishop, James J. Kim, Shelly R. Hovick, Leigha A. Senter, Daniel G. Stover
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Introduction Tumor genomic testing (TGT) is standard‐of‐care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was to evalua
Externí odkaz:
https://doaj.org/article/0f51ff3d583d483a9f9096298c4b2656
Publikováno v:
Cancer Medicine, Vol 11, Iss 21, Pp 4043-4052 (2022)
Abstract Background Identifying women with high risk of breast cancer is necessary to study high‐risk experiences and deliver risk‐management care. Risk prediction models estimate individuals' lifetime risk but have rarely been applied in communi
Externí odkaz:
https://doaj.org/article/092f94e9aaa34cffb14fef856bceaa55
Publikováno v:
BMC Women's Health, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Chemoprevention is one of several methods that have been developed to help high-risk women reduce their risk of breast cancer. Reasons for the low uptake of chemoprevention are poorly understood. This paper seeks a deeper understa
Externí odkaz:
https://doaj.org/article/1f044fffac4a45859f5acf734c37ca47
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:EPR23-087
Autor:
Tasleem J Padamsee, Rachel Mason, Anna Muraveva, Wilson S Figueroa, Paige A. Swinehart-Hord, Steven Kalister, Sagar Sardesai, Bushra Siddiqi, Jeffrey Hawley, Clayton Taylor, Doreen Agnese, Hayley Cassingham, Kevin Sweet, Noel Huber, Heidi Basinger
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:EPR23-082
Autor:
Leigha Senter, Deloris Veney, Taylor Surplus, Marcy Haynam, Elizabeth J. Adams, Heather Hampel, Amanda E. Toland, Carolyn J. Presley, Tasleem J. Padamsee, Clara N. Lee, Shelly R. Hovick, Daniel G. Stover
Publikováno v:
JCO Oncology Practice. 19:e8-e14
PURPOSE: Tumor genomic testing (TGT) has become increasingly adopted as part of standard cancer care for many cancers. Despite national guidelines around patient education before TGT, available evidence suggests that most patients' understanding of g
Publikováno v:
BMC Women's Health, Vol 21, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/604ea18b8cc747b7bedaab73e8c1e651
Autor:
Rachel J Meadows, Anna Muraveva, Christina Bijou, Kate Shane-Carson, Coralia Balasca, Celia E Wills, Lisa D Yee, Electra D Paskett, Tasleem J Padamsee
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:EPR22-113
Emotion and contralateral prophylactic mastectomy: A prospective study into surgical decision-making
Autor:
Peter J. Krasniak, Minh Nguyen, Sarah Janse, Crystal Phommasathit, Kaleigh Clevenger, Savannah Renshaw, Doreen M. Agnese, Tasleem J. Padamsee, Clara N. Lee
Publikováno v:
Psycho-oncologyREFERENCES. 31(10)
Patients with non-familial, unilateral breast cancer have a low risk of contralateral breast cancer. Thus, clinical studies have shown no survival benefit for patients who undergo contralateral prophylactic mastectomy (CPM) compared to those undergoi